Literature DB >> 18182679

The immunogenic potential of generic version of low-molecular-weight heparins may not be the same as the branded products.

Jawed Fareed, Rodger L Bick, Gundu Rao, Samuel Z Goldhaber, Arthur Sasahara, Harry L Messmore, Debra A Happensteadt, Andrew Nicolaides.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18182679     DOI： 10.1177/1076029607312278

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN： 1076-0296            Impact factor:   2.389


× No keyword cloud information.
  3 in total

1.  Pharmacological and clinical differences between low-molecular-weight heparins: implications for prescribing practice and therapeutic interchange.

Authors:  Geno J Merli; James B Groce
Journal:  P T       Date:  2010-02

2.  Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism.

Authors:  Jawed Fareed; Cafer Adiguzel; Indermohan Thethi
Journal:  Thromb J       Date:  2011-03-28

Review 3.  Therapeutic Interchange of Parenteral Anticoagulants: Challenges for Pharmacy and Therapeutics Committees.

Authors:  Alpesh Amin
Journal:  Pharmaceuticals (Basel)       Date:  2011-11-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.